State Street’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

State Street’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-77,700	Closed	-$1.66M	–	4427
2024 Q1	$1.66M	Buy	+77,700	New	+$929K	﹤0.01%	3335

State Street's FUSN Position: Q2 2024 in Review

State Street sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 77,700 shares — an estimated $1.66M sold.

State Street first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $1.66M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

State Street reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
State Street sold 77,700 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $1.66M.
State Street first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2024 and held it in 1 quarter.
State Street's Fusion Pharmaceuticals Inc. Common Shares position peaked at $1.66M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on State Street's 13F filing for Q2 2024, filed 14 Aug 2024.